Plain-English translation of NCT06694272 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Age Related Macular Degeneration research guide →This study is following people who have early signs of age-related macular degeneration (AMD) — a condition affecting the part of the eye needed for sharp, central vision. Researchers want to understand how the eye changes over time and find early warning signs before vision problems become serious. By doing this, they hope to develop better treatments that can slow or prevent vision loss.
Current eye exams aren't detailed enough to catch vision changes in the early stages of AMD, even though those changes might be happening. Finding these early signs could help doctors treat the disease sooner and prevent it from getting worse.
You likely qualify if…
You likely don't qualify if…
You will visit the research center for detailed eye exams and specialized vision tests at the start of the study and again after 4 years. At each visit, you'll have your vision measured in different lighting conditions, eye pressure checked, detailed photographs and imaging of the back of your eye, and a blood sample taken. The tests are non-invasive and painless, though some visits may take 2–3 hours. You'll also be tracked over the 4-year period to see how your eye condition changes over time.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
France
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Enrollment target
~120 participants
Started
April 2025
Primary completion
April 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Amelie Yavchitz
Fondation Ophtalmologique Adolphe de Rothschild
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.